UPDATE | April 3, 2026
Which digital technologies have delivered tangible operational value over the past 12–18 months and which remain over-hyped?
Digital technologies are delivering real value in biologics manufacturing, especially in strengthening data compliance and process understanding.
From MES-based eMBR systems improving traceability and reducing errors, to CFD supporting more efficient scale-up and tech transfer, these tools are enhancing operational reliability across the board. At the same time, fully autonomous AI-driven manufacturing remains more aspirational than practical due to interoperability, integration, and regulatory challenges.
In this roundtable, Hongwoo Joo, Director of Digital Excellence at Samsung Biologics, shares his perspective on what is delivering real impact today.
Digital technologies are delivering real value in biologics manufacturing, especially in strengthening data compliance and process understanding.
From MES-based eMBR systems improving traceability and reducing errors, to CFD supporting more efficient scale-up and tech transfer, these tools are enhancing operational reliability across the board. At the same time, fully autonomous AI-driven manufacturing remains more aspirational than practical due to interoperability, integration, and regulatory challenges.
In this roundtable, Hongwoo Joo, Director of Digital Excellence at Samsung Biologics, shares his perspective on what is delivering real impact today.
Share article
Related Content